A5102801628- Hepatitis C virus research
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- Orthopedic Infections and Treatments
- Tracheal and airway disorders
- Bacterial Identification and Susceptibility Testing
- Gestational Trophoblastic Disease Studies
- Esophageal and GI Pathology
- Ammonia Synthesis and Nitrogen Reduction
- HIV/AIDS drug development and treatment
- Liver Disease and Transplantation
- Dialysis and Renal Disease Management
- Cancer Genomics and Diagnostics
- Esophageal Cancer Research and Treatment
- Amino Acid Enzymes and Metabolism
- Cancer Cells and Metastasis
- Infective Endocarditis Diagnosis and Management
- Cancer Immunotherapy and Biomarkers
- Diagnosis and treatment of tuberculosis
Hospital Universitari de Girona Doctor Josep Trueta
2023
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2017-2018
Hospital Clínic de Barcelona
2017-2018
Centro de Investigación Biomédica en Red
2017-2018
Universitat de Barcelona
2009-2018
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
2017
Bellvitge University Hospital
2009-2014
Institut d'Investigació Biomédica de Bellvitge
2010-2014
Summary Background A few cases of hepatitis B virus ( HBV ) reactivation during anti‐viral therapy against C HCV have been reported. However, the information regarding real impact this phenomenon is scarce. Aim To evaluate risk with an interferon‐free regimen direct‐acting anti‐virals DAA s). Methods Observational and prospective study 352 patients receiving s between September 2015 May 2016. ‐ DNA ALT levels were monitored at baseline, week 4 therapy, end treatment 12 weeks after...
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTA New Route to 15N-Labeled, N-Alkyl, and N-Amino Nucleosides via N-Nitration of Uridines InosinesXavier Ariza, Valenti Bou, Jaume VilarrasaCite this: J. Am. Chem. Soc. 1995, 117, 13, 3665–3673Publication Date (Print):April 1, 1995Publication History Published online1 May 2002Published inissue 1 April 1995https://pubs.acs.org/doi/10.1021/ja00118a002https://doi.org/10.1021/ja00118a002research-articleACS PublicationsRequest reuse permissionsArticle...
Treatment of locally advanced esophageal cancers with high-dose definitive concomitant chemoradiotherapy can lead to high-grade strictures, or, rarely, total obliteration the lumen. Strictures be successfully treated various endoscopic techniques; however, complete obstruction is a technically challenging problem. Anterograde techniques carry risk perforation or bleeding. A combined anterograde–retrograde dilation technique, described in few reports, another option but requires retrograde...
Summary The emergence of resistance‐associated substitutions (RASs) can compromise the high efficacy direct‐acting antivirals (DAAs). Little is known about RASs selection at very early time points during DAA treatment. Therefore, we analyzed potential immediately after therapy initiation. Samples 71 patients treated with different DAAs were collected baseline, (hours 4 and 8; days 1‐7; weeks 2‐4) or until target not detected. HCV‐RNA levels determined by qPCR, detected deep sequencing....
TNBC is an aggressive breast cancer subtype that needs further molecular characterization to develop targeted therapy improve its outcome. The ability of BCSCs evade the immune system one resistance mechanisms chemotherapy, remains standard treatment. Neoadjuvant chemotherapy (NACT) could induce changes in subpopulation and patients' response. New therapeutic strategies based on blocking this are being evaluated. In a retrospective study, we included 25 early patients resistant NACT...